Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Melanoma × Dermatologic × Clear all

Phase

Status

Recruiting 2 Unknown 1 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 427 Lymphoma, T-Cell, Cutaneous 82 Carcinoma, Non-Small-Cell Lung 74 Mycosis Fungoides 66 Neoplasm Metastasis 60 Skin Neoplasms 57 Sezary Syndrome 56 Neoplasms 54 Carcinoma, Renal Cell 54 Lymphoma, Non-Hodgkin 47 Lymphoma 47 Lymphoma, Large B-Cell, Diffuse 46 Breast Neoplasms 46 Leukemia, Lymphocytic, Chronic, B-Cell 44 Lymphoma, Follicular 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Lymphoma, Mantle-Cell 40 Lymphoma, B-Cell, Marginal Zone 40 Hodgkin Disease 38 Burkitt Lymphoma 38 Lymphoma, Large-Cell, Immunoblastic 37 Squamous Cell Carcinoma of Head and Neck 36 Ovarian Neoplasms 36 Colorectal Neoplasms 36 Multiple Myeloma 34 Uveal Melanoma 30 Lymphoma, Large-Cell, Anaplastic 29 Leukemia, Myeloid, Acute 29 Leukemia, Hairy Cell 29 Sarcoma 28

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03407170 2020-07-15

KEYNOTE-161

Merck Sharp & Dohme LLC

Phase 2 Terminated

1 enrolled 3 charts

Advanced Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡